Recruiting EARLY_PHASE1 Autism Spectrum Disorder

New treatment option for Autism Spectrum Disorder

Official title Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design

ClinicalTrials.gov ID: NCT07432776

What this study is testing

What it's testing
The goal of this clinical trial is to learn if an 8-week, community-based pickleball program can improve sensory-motor function and reduce the severity of core autism symptoms in adults ages 18-45 with autism spectrum disorder (ASD) who can participate independently without a caregiver. The main questions it aims to answer are: 1.
  • Phase 1: an early, usually small safety study
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 45

You may be able to join if

  • Aged 18-45 years
  • Clinical diagnosis of autism spectrum disorder (ASD)
  • Able to participate in group-based activities without caregiver support
  • Able to understand English and independently communicate without assistance
  • Available for at least two sessions per week for the intervention dates

You likely can't join if

  • Clinical diagnosis of intellectual disability (ID)
  • Does not have normal or corrected-to-normal vision
  • Actively participating in a racquet sport ≥1 time per week
  • Use of mobility aids
  • Moderate-to-severe joint pain (WOMAC pain subscale)
  • Neurologic conditions (cerebral palsy, severe head injury, progressive neurological disorders, epilepsy)
See the full eligibility criteria
Who can join
  • Aged 18-45 years
  • Clinical diagnosis of autism spectrum disorder (ASD)
  • Able to participate in group-based activities without caregiver support
  • Able to understand English and independently communicate without assistance
  • Available for at least two sessions per week for the intervention dates
  • Access to reliable transportation to the intervention site
  • Able to provide informed consent (i.e., no legally authorized representative)
  • Pre-exercise screening indicates medical clearance is not needed, based on ACSM guidelines
What rules you out
  • Clinical diagnosis of intellectual disability (ID)
  • Does not have normal or corrected-to-normal vision
  • Actively participating in a racquet sport ≥1 time per week
  • Use of mobility aids
  • Moderate-to-severe joint pain (WOMAC pain subscale)
  • Neurologic conditions (cerebral palsy, severe head injury, progressive neurological disorders, epilepsy)
  • Individuals who cannot provide their own informed consent (i.e., have a legally authorized representative)
  • Individuals who require medical clearance for exercise based on the ACSM preparticipation screening questionnaire

The study team makes the final eligibility decision.

Where it's taking place

  • Middletown, Pennsylvania, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 45 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Middletown, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.